Observational Study of Infants Born at 34 to 37 Weeks of Gestation Until the Age of 1 Year
- Conditions
- Developmental DelayHypoglycemiaJaundiceHypothermiaRespiratory DistressFeeding Intolerance
- Registration Number
- NCT00550069
- Lead Sponsor
- Sheba Medical Center
- Brief Summary
Late preterm infants are at an increased risk for short and long term morbidity (during the 1st year of life, their neurodevelopmental status may also be delayed as compared to infants born at term). The term "near term infants" is probably a deceiving one.
- Detailed Description
The study will include all near term infants born at 3 Israeli medical centers during a one year period.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
- Gestational age 34wks- 37wks
- Singleton
- Without chromosomal abnormalities or malformations
Exclusion Criteria
- No chromosomal abnormalities
- Malformations
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method neurodevelopmental, health and growth status in late preterm infants vs. controls within the first year of life one year
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie developmental delays in late preterm infants as studied in NCT00550069?
How does the clinical course of late preterm infants compare to standard-of-care outcomes in similar cohorts?
Are there specific biomarkers that predict neurodevelopmental outcomes in infants born at 34-37 weeks gestation?
What adverse events are commonly observed in late preterm infants and how were they managed in the Sheba Medical Center study?
What combination therapies or interventions are being explored for late preterm infants with hypoglycemia and respiratory distress?
Trial Locations
- Locations (1)
Sheba Medical Center
🇮🇱Tel Hashomer, Israel
Sheba Medical Center🇮🇱Tel Hashomer, IsraelIris Morag, MDPrincipal Investigator